Compare Ginkgo Bioworks Holdings Inc (DNA) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs ProShares Ultra Gold ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while ProShares Ultra Gold ETF trades at $52.68. The key difference: ProShares Ultra Gold ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | UGL | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $16.14 | $85.62 |
52-Week Low | $5.48 | $34.37 |
Enterprise Value | $607.68M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
